Home/Pipeline/Novel oncology agents

Novel oncology agents

Oncology

Phase 1/Phase 2Active

Key Facts

Indication
Oncology
Phase
Phase 1/Phase 2
Status
Active
Company

About R-Pharm

R-Pharm is a major, fully-integrated Russian pharmaceutical player with a strategic focus on localizing advanced drug production and developing innovative therapies. The company leverages extensive partnerships with global biopharma leaders to in-license and co-develop products for the Russian and CIS markets, while also advancing its own R&D pipeline. Its significant manufacturing capabilities and government contracts position it as a key domestic supplier, particularly in oncology and critical care. The company's strategy is heavily aligned with Russia's national pharmaceutical import substitution policies.

View full company profile